Jose Luis Sanchez-Trincado

6PUBLICATIONS
27CO-AUTHORS
Mining, energy and natural resources lawOccupational epidemiologyInnate immunityNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

|Nov 27, 2025
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Carlos Martínez-Rivera, Marina Blanco-Aparicio, Francisco Casas-Maldonado

|May 14, 2025
Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study.

Pilar Ausín, María Eugenia Navarrete-Rouco, Luis Carazo

|Nov 27, 2021
Immune Tolerance in the Oral Mucosa.

Hector F Pelaez-Prestel, Jose L Sanchez-Trincado, Esther M Lafuente

|Mar 16, 2021
Huntington's disease-specific mis-splicing unveils key effector genes and altered splicing factors.

Ainara Elorza, Yamile Márquez, Jorge R Cabrera

|Feb 16, 2018
Fundamentals and Methods for T- and B-Cell Epitope Prediction.

Jose L Sanchez-Trincado, Marta Gomez-Perosanz, Pedro A Reche

Pageof 1

Frequent Collaborators

3 joint publications

Alicia Padilla-Galo

2 joint publications

Pedro A Reche

2 joint publications

Elisa Luzon

1 joint publications

Marta Gomez-Perosanz